Back

Heterogeneity of survival outcomes in ypN1 breast cancer after neoadjuvant therapy: The role of residual nodal burden in axillary de-escalation

2026-03-05 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundThe management of residual axillary disease after neoadjuvant therapy (NAT) remains controversial, as current recommendations often treat ypN1 breast cancer as a homogeneous entity despite potential prognostic heterogeneity. Evidence supporting uniform axillary surgical strategies across different levels of residual nodal burden is limited. We investigated whether survival associations related to axillary surgical evaluation differ according to residual nodal burden in ypN1 disease, us...

Predicted journal destinations